ALLYRNA
Latest round
- Seed
Last raised
- Aug 2026
Total raised
- $10M
Investors
- 8
About ALLYRNA
, trading as ALLYRNA, was established by Professor He Chuan of the University of Chicago, an expert in RNA epigenetics and recipient of the Wolf Prize in Chemistry. The company’s development strategy centers on drug innovation, aiming to address unmet needs in cancer treatment. ALLYRNA is building a technology platform focused on sensitizers for radiotherapy and immunotherapy. The company's pipeline emphasizes first-in-class small molecule drugs that enhance therapeutic responses in oncology, with applications in tumor treatment and potentially other related disease areas. As a research-driven biotechnology company, ALLYRNA is currently in the development stage. Future revenue is expected to derive from licensing of intellectual property, partnerships with pharmaceutical companies, and eventual commercialization of its proprietary drug candidates. ALLYRNA will continue to advance its core R&D projects and optimize its drug candidates, improve its preclinical development system and global intellectual property layout, further strengthen its core talent team, and accelerate the translation of globally competitive original scientific research results into innovative drugs.
Who invested in ALLYRNA
8 investors across 2 rounds
See all investors in ALLYRNA
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ALLYRNA
Who invested in ALLYRNA?
ALLYRNA has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ALLYRNA raised?
ALLYRNA has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did ALLYRNA last raise money?
ALLYRNA's most recent round on record is a Seed, in Aug 2026.
What does ALLYRNA do?
, trading as ALLYRNA, was established by Professor He Chuan of the University of Chicago, an expert in RNA epigenetics and recipient of the Wolf Prize in Chemistry.
Where is ALLYRNA headquartered?
ALLYRNA is headquartered in Hong Kong, Hong Kong SAR - China.
Which VCs invest in companies like ALLYRNA?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at ALLYRNA's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Seed
Raising like ALLYRNA? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.